Information plus patient preferences can help in sorting through reconstruction options, according to plastic and reconstructive surgery
September 26, 2014 - Decision analysis techniques can help surgeons and patients evaluate alternatives for breast reconstruction-leading to a "good decision" that reflects the woman's preferences and values, according to an article in the October issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
The special topic article by Mia K. Markey, PhD, and colleagues of The University of Texas at Austin and The University of Texas MD Anderson Cancer Center, Houston, introduces plastic surgeons to the use of decision analysis to help women navigate decisions about breast reconstruction after mastectomy for breast cancer. "Decision analysis provides structure for methodic, thoughtful decision-making through the use of reason, logic, and mathematics," the authors write.
Decision Analysis Helps Sort Through Breast Reconstruction Options
Decision analysis is defined as " an exhaustive, iterative process that involves identifying alternatives, obtaining information about the uncertainty of outcomes, and clarifying preferences and values." Routinely used in business, decision analysis is increasingly applied to complex medical decisions as well.
Women facing breast reconstruction may need to sort through a bewildering array of options-such as immediate versus delayed reconstruction, using implants or their own tissues-while dealing with the emotions of their breast cancer diagnosis and the uncertainty characteristic of difficult decisions. "When making decisions about breast reconstruction, it is the patient who must live with the consequences," Dr Markey and coauthors write.
They outline a process that plastic surgeons can follow in guiding patients through decision analysis. The surgeon provides information about the available alternatives for breast reconstruction; and the probability of different outcomes-for example, the need for repeated surgeries, possible complications, and aesthetic results. Based on the patient's preferences, her values are assigned to possible outcomes.
This information is used to create a "decision tree," incorporating the options, the likelihood of various outcomes, and the values assigned to each outcome. Dr Markey and coauthors walk readers through the decision analysis process for a hypothetical patient considering breast reconstruction. Their article includes a link to an educational spreadsheet that shows surgeons an example of how the decision analysis process works.
'Good Decisions,' Reflecting Women's Preferences and Values
A step called sensitivity analysis weighs the impact of changing different variables that might affect the decision-for example, different assumptions regarding the risk of complications or out-of-pocket costs. "If the decision remains the same, it is robust and likely good," the authors write.
Dr Markey and colleagues emphasize that decision analysis doesn't guarantee a good outcome of breast reconstruction. However, it can help the patient reach a "good decision"-defined as "one that takes into account her preferences and the uncertainties inherent in reconstructive surgery." The authors add, "By making good decisions, patient outcomes may be improved."
Although it can be "computationally intensive," Dr Markey and coauthors believe decision analysis has important benefits for women facing decisions about breast reconstruction. They write, "Ideally, its application will attenuate worry, safeguard against regret, transmute uncertainty into certainty, and grant some measure of peace in what may ultimately be a very difficult decision."
The special topic paper appears as ASPS prepares to observe National Breast Reconstruction Awareness (BRA) Day on October 15, 2014. National BRA Day seeks to "close the loop on breast cancer" by helping to ensure that women know their options for breast reconstruction after mastectomy. To learn more, visit https://www.bradayusa.org/.
Plastic and Reconstructive Surgery® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
About Plastic and Reconstructive Surgery
For more than 60 years, Plastic and Reconstructive Surgery® (https://journals.lww.com/plasreconsurg/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
About ASPS
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 7,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery. You can learn more and visit the American Society of Plastic Surgeons at https://www.plasticsurgery.org or https://www.facebook.com/PlasticSurgeryASPS and https://www.twitter.com/ASPS_news.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Follow our official Twitter handle: @WKHealth.
